Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in MRK — Merck & Co., Inc.

CIK 72971 SAN FRANCISCO, CA
Back to MRK Full portfolio

Position in MRK

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$1,376,940,982
+$214,006,295 QoQ
Shares Held
11,446,845
+3.6% QoQ
Ownership
0.463%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96.16538880363979.ToString("F0")% Shared 0.ToString("F0")% None 3.83461119636022.ToString("F0")%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Mar 31, 2026
CallValue
$58,112,099
CallShares
483,100
PutValue
$8,420,300
PutShares
70,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $16,837,469,618 across 20 Drug Manufacturers - General names. MRK ranks #5 (8.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JNJ
Johnson & Johnson
 16,925,454 $4,137,257,974
2 LLY
ELI LILLY & Co
 4,405,844 $4,052,363,133
3 AMGN
Amgen Inc
 7,088,010 $2,493,916,315
4 ABBV
AbbVie Inc.
 8,909,597 $1,937,748,249
5 MRK
Merck & Co., Inc.
This page 		11,446,845 $1,376,940,982
6 GILD
Gilead Sciences, Inc.
 6,628,441 $923,805,819
7 PFE
Pfizer Inc
 19,533,309 $548,495,315
8 BMY
Bristol Myers Squibb Co
 5,946,447 $360,652,008

All Filings in MRK

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,376,940,982 11,446,845
2026-03-31 $8,420,300 70,000
2026-03-31 $58,112,099 483,100
2025-12-31 $38,967,252 370,200
2025-12-31 $1,162,934,687 11,048,211
2025-12-31 $36,314,700 345,000
2025-09-30 $876,947,639 10,448,560
2025-09-30 $63,367,150 755,000
2025-09-30 $48,259,750 575,000
2025-06-30 $901,085,243 11,383,088
2025-06-30 $63,328 800
2025-06-30 $11,478,200 145,000
2025-03-31 $1,884,960 21,000
2025-03-31 $5,241,984 58,400
2025-03-31 $1,068,067,880 11,899,152
2024-12-31 $1,478,848,587 14,865,788
2024-12-31 $2,059,236 20,700
2024-09-30 $3,895,108 34,300
2024-09-30 $1,694,067,749 14,917,821
2024-09-30 $3,940,532 34,700
2024-06-30 $6,586,160 53,200
2024-06-30 $1,683,680 13,600
2024-06-30 $1,933,503,446 15,617,960
2024-03-31 $5,330,780 40,400
2024-03-31 $13,947,115 105,700
2024-03-31 $2,160,905,562 16,376,700
2023-12-31 $31,190,622 286,100
2023-12-31 $1,772,939,817 16,262,519
2023-12-31 $21,804 200
2023-09-30 $2,759,060 26,800
2023-09-30 $1,689,847,756 16,414,257
2023-09-30 $20,590 200
2023-06-30 $23,078 200
2023-06-30 $2,030,850,379 17,599,882
2023-06-30 $3,092,452 26,800
2023-03-31 $3,095,949 29,100
2023-03-31 $1,901,327,711 17,871,301
2023-03-31 $819,203 7,700
2022-12-31 $2,033,153,310 18,324,951
2022-12-31 $21,968,100 198,000
2022-12-31 $22,190 200
2022-09-30 $2,153,000 25,000
2022-09-30 $59,276,396 688,300
2022-09-30 $1,627,420,316 18,897,124
2022-06-30 $18,224,883 199,900
2022-06-30 $1,741,680,679 19,103,660
2022-06-30 $14,331,924 157,200
2022-03-31 $1,643,617,555 20,031,902
2022-03-31 $9,435,750 115,000
2022-03-31 $13,480,815 164,300

Report a Problem

Category
Description
Email (optional, for follow-up)